Hospital
Stafford Hospital, LLC
Stafford Hospital, LLC was paid $25.29M by Medicaid between Jan 2018 and Dec 2024, across 202 billing codes. Its largest line is 99284, emergency room visit (serious) — 21% of everything it billed.
33Billing provider infoSTAFFORD HOSPITAL, LLC
STAFFORD, VA 22554
STAFFORD, VA 22554
33aNPI1043343304assigned 03/14/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$25.29M
24GClaims590,226
24DCodes billed202
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Virginia
Rank by total paid#28 of 80
Median peer was paid$14.69M
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official NEWMAN, CHRISTOPHER controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38,916 | $1.32M | |
| 2019 | 79,336 | $2.75M | |
| 2020 | 73,925 | $2.69M | |
| 2021 | 96,213 | $3.42M | |
| 2022 | 99,107 | $4.10M | |
| 2023 | 114,496 | $5.96M | |
| 2024incomplete | 88,233 | $5.07M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 27,789 | 24,012 | $5.40M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 17,708 | 15,913 | $3.14M |
| 96361 | Intravenous infusion, hydration; each additional hour | 12% | 12,970 | 10,160 | $3.04M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.7% | 10,169 | 9,165 | $1.70M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.6% | 7,304 | 6,515 | $1.66M |
| 41899 | Unlisted procedure, dentoalveolar structures | 6.5% | 868 | 832 | $1.64M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.6% | 4,968 | 4,478 | $1.16M |
| G0378 | Hospital observation service, per hour | 3.9% | 4,036 | 3,238 | $993K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.8% | 4,503 | 4,103 | $972K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.2% | 4,120 | 3,545 | $566K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.6% | 1,612 | 1,455 | $416K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 3,749 | 3,093 | $364K |
190 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.3% | 1,457 | $320K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 812 | $275K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.1% | 447 | $273K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.1% | 4,262 | $267K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,188 | $237K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 836 | $212K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,961 | $193K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,074 | $189K |
| 76830 | Ultrasound, transvaginal | <1% | 1,798 | $182K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,142 | $179K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,163 | $130K |
| 80053 | Comprehensive metabolic panel | <1% | 29,025 | $118K |
| 93971 | <1% | 1,191 | $115K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 980 | $115K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 606 | $102K |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 2,640 | $98K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 338 | $83K |
| 76770 | <1% | 521 | $74K | |
| 76801 | <1% | 1,443 | $66K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,384 | $64K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,490 | $61K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,911 | $56K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,447 | $50K |
| 76536 | <1% | 376 | $49K | |
| 87400 | <1% | 3,167 | $41K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 98 | $40K |
| 59025 | Fetal non-stress test | <1% | 327 | $37K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 114 | $36K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 6,863 | $32K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 5,425 | $29K |
| 83880 | <1% | 2,818 | $25K | |
| 87040 | <1% | 2,571 | $25K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 13,058 | $19K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 26 | $18K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 213 | $18K |
| 80329 | <1% | 1,424 | $17K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 30,363 | $17K |
| 93000 | <1% | 11,455 | $16K | |
| 97161 | <1% | 188 | $16K | |
| 85379 | <1% | 2,805 | $15K | |
| 97162 | <1% | 61 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,309 | $14K |
| 71045 | Radiologic examination, chest; single view | <1% | 9,148 | $14K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 111 | $13K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 203 | $13K |
| 84484 | <1% | 10,403 | $13K | |
| 73564 | <1% | 1,265 | $12K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 287 | $12K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 262 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,482 | $11K |
| 86850 | <1% | 1,450 | $11K | |
| 93017 | <1% | 66 | $10K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 292 | $7K |
| 93970 | <1% | 54 | $7K | |
| 74018 | <1% | 1,681 | $7K | |
| A9270 | Non-covered item or service | <1% | 66,636 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,856 | $6K |
| 12001 | <1% | 27 | $6K | |
| 80061 | Lipid panel | <1% | 1,268 | $5K |
| 76870 | <1% | 45 | $5K | |
| 71250 | <1% | 54 | $5K | |
| 83735 | <1% | 14,043 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,334 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 10,763 | $4K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 13 | $4K |
| 73030 | <1% | 578 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,788 | $4K |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 3,203 | $4K |
| 72110 | <1% | 367 | $4K | |
| 72100 | <1% | 634 | $4K | |
| 83605 | <1% | 3,349 | $4K | |
| 87428 | <1% | 4,276 | $4K | |
| 84703 | <1% | 8,253 | $4K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 8,561 | $3K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 13 | $3K |
| 76937 | <1% | 43 | $3K | |
| 83690 | <1% | 10,091 | $3K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 207 | $3K |
| J3490 | Unclassified drugs | <1% | 7,173 | $3K |
| 72141 | <1% | 13 | $3K | |
| 96376 | <1% | 4,275 | $3K | |
| 81001 | <1% | 12,504 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 431 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,245 | $2K |
| 73630 | <1% | 837 | $2K | |
| 82948 | <1% | 7,773 | $2K | |
| 96367 | <1% | 69 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 13,073 | $2K |
| 84702 | <1% | 1,962 | $2K | |
| 80306 | <1% | 2,448 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,616 | $2K |
| 73610 | <1% | 856 | $2K | |
| 86900 | <1% | 3,052 | $2K | |
| 80320 | <1% | 2,052 | $2K | |
| 86901 | <1% | 3,051 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,429 | $2K |
| 85027 | <1% | 2,224 | $2K | |
| 85610 | <1% | 6,132 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 5,400 | $1K |
| 81025 | <1% | 3,361 | $1K | |
| 73130 | <1% | 460 | $1K | |
| 72050 | <1% | 114 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 703 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,471 | $1K |
| 81003 | <1% | 8,375 | $952.86 | |
| 82330 | <1% | 844 | $876.90 | |
| 82565 | <1% | 1,950 | $875.24 | |
| 87807 | <1% | 996 | $860.30 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,427 | $799.23 |
| 73502 | <1% | 105 | $710.46 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,239 | $651.10 |
| 82550 | <1% | 607 | $547.73 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 42 | $524.02 |
| 85018 | <1% | 1,003 | $500.10 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,349 | $477.15 |
| 73110 | <1% | 116 | $469.74 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,457 | $433.77 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,170 | $398.36 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,482 | $374.90 |
| 85007 | <1% | 1,110 | $364.70 | |
| 86140 | <1% | 165 | $322.81 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 607 | $322.49 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,660 | $319.65 |
| 90715 | <1% | 13 | $302.61 | |
| 87210 | <1% | 925 | $294.61 | |
| 84132 | <1% | 894 | $291.45 | |
| 85014 | <1% | 485 | $258.88 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,969 | $244.96 |
| 72040 | <1% | 16 | $227.29 | |
| 86308 | <1% | 1,041 | $218.73 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,376 | $212.59 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,844 | $205.67 |
| J2704 | Injection, propofol, 10 mg | <1% | 5,661 | $192.83 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 81 | $178.78 |
| 90686 | <1% | 16 | $172.76 | |
| 72072 | <1% | 39 | $169.21 | |
| 82803 | <1% | 699 | $162.46 | |
| 87186 | <1% | 942 | $149.78 | |
| 87641 | <1% | 17 | $145.28 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,987 | $117.89 |
| 87088 | <1% | 861 | $112.78 | |
| 84439 | <1% | 27 | $108.22 | |
| 82947 | <1% | 734 | $107.38 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 1,380 | $95.81 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 756 | $91.88 |
| J7070 | Infusion, d5w, 1000 cc | <1% | 421 | $85.73 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 12 | $83.30 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,001 | $81.34 |
| 85651 | <1% | 88 | $76.10 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 625 | $74.14 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 82 | $71.38 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 717 | $65.37 |
| 71101 | <1% | 15 | $64.57 | |
| 82728 | <1% | 15 | $64.20 | |
| 85730 | <1% | 190 | $62.62 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 878 | $57.88 |
| 85652 | <1% | 76 | $45.84 | |
| 88342 | <1% | 53 | $23.78 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 446 | $20.35 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 162 | $19.46 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 183 | $18.18 |
| 84295 | <1% | 240 | $17.17 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 223 | $16.91 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 150 | $16.12 |
| 82570 | <1% | 12 | $13.01 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 228 | $12.46 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 313 | $10.96 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 59 | $4.36 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 42 | $3.58 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 47 | $2.01 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 353 | $1.02 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 17 | $0.69 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 67 | $0.51 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 646 | $0.00 |
| 85008 | 0% | 52 | $0.00 | |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 25 | $0.00 |
| 87077 | 0% | 12 | $0.00 | |
| 87205 | 0% | 29 | $0.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 33 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 14 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 41 | $0.00 |
| 0352U | 0% | 14 | $0.00 | |
| 86780 | 0% | 15 | $0.00 | |
| 81015 | 0% | 44 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 1,225 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 346 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 16 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 99 | $0.00 |
| 73590 | 0% | 15 | $0.00 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNEWMAN, CHRISTOPHER (CEO)
| Provider | Location | Paid |
|---|---|---|
| Mary Washington Hospital INC. | Fredericksburg, VA | $80.25M |
| Mary Washington Healthcare Physicians | Fredericksburg, VA | $13.36M |
| Camelback Recovery Treatment Center | Phoenix, AZ | $2.96M |
| Mary Washington Healthcare Providers LLC | Fredericksburg, VA | $2.50M |
| Mary Washington Hospital, INC. | Fredericksburg, VA | $1.78M |
| MWHC Urgent Care LLC | King George, VA | $792K |
| MWHC Urgent Care LLC | Stafford, VA | $536K |
| Mary Washington Hospital, INC. | Fredericksburg, VA | $394K |
| Mary Washington Eye Care Center, LLC | Fredericksburg, VA | $375K |
| MWHC Urgent Care LLC | Fredericksburg, VA | $91K |
| Mary Washington Healthcare Specialty Services LLC | Fredericksburg, VA | $69K |
| Mary Washington Healthcare Clinical Services, INC. | Fredericksburg, VA | $65K |
| Camelback Physicians Group LLC | Phoenix, AZ | $52K |
| Fredericksburg Ambulatory Surgery Center, LLC | Fredericksburg, VA | $20K |
| MWHC Urgent Care LLC | Stafford, VA | $14K |
| Stafford Hospital, LLC | Stafford, VA | $11.96 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.